Cryz SJ - Search Results

1

Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.

Fries LF, Gordon DM, Schneider I, Beier JC, Long GW, Gross M, Que JU, Cryz SJ, Sadoff JC. Fries LF, et al. Among authors: cryz sj. Infect Immun. 1992 May;60(5):1834-9. doi: 10.1128/iai.60.5.1834-1839.1992. Infect Immun. 1992. PMID: 1563771 Free PMC article.

2

Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine.

Cryz SJ Jr, Fürer E, Que JU. Cryz SJ Jr, et al. Infect Immun. 1991 Jan;59(1):45-50. doi: 10.1128/iai.59.1.45-50.1991. Infect Immun. 1991. PMID: 1898901 Free PMC article.

3

Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines.

Cryz SJ Jr, Cross AS, Sadoff JC, Fürer E. Cryz SJ Jr, et al. Infect Immun. 1990 Feb;58(2):373-7. doi: 10.1128/iai.58.2.373-377.1990. Infect Immun. 1990. PMID: 2105272 Free PMC article.

4

Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans.

Cryz SJ Jr, Sadoff JC, Fürer E. Cryz SJ Jr, et al. Infect Immun. 1988 Jul;56(7):1829-30. doi: 10.1128/iai.56.7.1829-1830.1988. Infect Immun. 1988. PMID: 2454893 Free PMC article. Clinical Trial.

5

Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoites.

Que JU, Cryz SJ Jr, Ballou R, Fürer E, Gross M, Young J, Wasserman GF, Loomis LA, Sadoff JC. Que JU, et al. Among authors: cryz sj jr. Infect Immun. 1988 Oct;56(10):2645-9. doi: 10.1128/iai.56.10.2645-2649.1988. Infect Immun. 1988. PMID: 3047062 Free PMC article.

6

Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine.

Cryz SJ Jr, Furer E, Sadoff JC, Germanier R. Cryz SJ Jr, et al. Infect Immun. 1986 Apr;52(1):161-5. doi: 10.1128/iai.52.1.161-165.1986. Infect Immun. 1986. PMID: 3082756 Free PMC article.

7

Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates.

Cryz SJ Jr, Lang AB, Sadoff JC, Germanier R, Fürer E. Cryz SJ Jr, et al. Infect Immun. 1987 Jul;55(7):1547-51. doi: 10.1128/iai.55.7.1547-1551.1987. Infect Immun. 1987. PMID: 3110065 Free PMC article.

8

Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously.

Edelman R, Taylor DN, Wasserman SS, McClain JB, Cross AS, Sadoff JC, Que JU, Cryz SJ. Edelman R, et al. Among authors: cryz sj. Vaccine. 1994 Nov;12(14):1288-94. doi: 10.1016/s0264-410x(94)80054-4. Vaccine. 1994. PMID: 7856293 Clinical Trial.

9

Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis.

Schaad UB, Lang AB, Wedgwood J, Ruedeberg A, Que JU, Fürer E, Cryz SJ Jr. Schaad UB, et al. Among authors: cryz sj jr. Lancet. 1991 Nov 16;338(8777):1236-7. doi: 10.1016/0140-6736(91)92103-9. Lancet. 1991. PMID: 1682645 Clinical Trial.

10

Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humans.

Cryz SJ Jr, Cross AS, Sadoff JC, Wegmann A, Que JU, Fürer E. Cryz SJ Jr, et al. J Infect Dis. 1991 May;163(5):1040-5. doi: 10.1093/infdis/163.5.1040. J Infect Dis. 1991. PMID: 1708398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters